{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:55:12Z","timestamp":1793919312252,"version":"4.8.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.seizure.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T20:46:09Z","timestamp":1662410769000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis"],"prefix":"10.1016","volume":"101","author":[{"given":"Ratnav","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3587-0968","authenticated-orcid":false,"given":"Sudhir C","family":"Sarangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"10053","key":"10.1016\/j.seizure.2022.09.003_bib0002","first-page":"1545","volume":"388","author":"Lipton","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.003_bib0003","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.09.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.07.040","article-title":"Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: could they have a neuroendocrine correlation in persons with epilepsy?","volume":"100","author":"Sarangi","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.seizure.2022.09.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106947","article-title":"Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: a cross-sectional study","volume":"105","author":"Kumar","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.seizure.2022.09.003_bib0006","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0007","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/14737175.2016.1158101","article-title":"Exploring novel AEDs from drugs used for treatment of non-epileptic disorders","volume":"16","author":"Du","year":"2016","journal-title":"Expert. Rev. Neurother."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0008","first-page":"31","article-title":"Dipeptidyl peptidase-4 inhibitor ameliorates status epilepticus seizures and cognitive disturbances in a rat model of temporal lobe epilepsy","volume":"6","author":"Jamali-raoufi","year":"2018","journal-title":"J. Basic Clin. Pathophysiol."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11011-017-0132-z","article-title":"Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy","volume":"33","author":"Mehrabi","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1139\/cjpp-2018-0266","article-title":"Effects of metformin on apoptosis and \u03b1-synuclein in a rat model of pentylenetetrazole-induced epilepsy","volume":"97","author":"Hussein","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0011","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2014.04.130","article-title":"Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice","volume":"448","author":"Zhao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.seizure.2022.09.003_bib0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2017.01.157","article-title":"Chronic metformin treatment facilitates seizure termination","volume":"484","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.seizure.2022.09.003_bib0013","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10571-018-0611-8","article-title":"Metformin plus caloric restriction show antiepileptic effects mediated by mTOR pathway inhibition","volume":"38","author":"Osornio","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1132-3","article-title":"Treatment with metformin in twelve patients with Lafora disease","volume":"14","author":"Bisulli","year":"2019","journal-title":"Orphanet. J. Rare. Dis."},{"issue":"5","key":"10.1016\/j.seizure.2022.09.003_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNR.0000000000000751","article-title":"4-PBA and metformin decrease sensitivity to PTZ-induced seizures in a malin knockout model of Lafora disease","volume":"28","author":"S\u00e1nchez-Elexpuru","year":"2017","journal-title":"Neuroreport"},{"issue":"11","key":"10.1016\/j.seizure.2022.09.003_bib0016","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1007\/s12035-020-02062-6","article-title":"Metabolic alterations predispose to seizure development in high-fat diet-treated mice: the role of metformin","volume":"57","author":"Nesci","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118066","article-title":"Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats","volume":"257","author":"Vazifehkhah","year":"2020","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.seizure.2022.09.003_bib0018","doi-asserted-by":"crossref","first-page":"581","DOI":"10.12669\/pjms.333.11996","article-title":"Metformin attenuate PTZ-induced apoptotic neurodegeneration in human cortical neuronal cells","volume":"33","author":"Bibi","year":"2017","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.seizure.2022.09.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101849","article-title":"The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy","volume":"109","author":"Vazifehkhah","year":"2020","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.seizure.2022.09.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106893","article-title":"Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats","volume":"104","author":"Mohamed","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.seizure.2022.09.003_bib0021","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jns.2013.07.160","article-title":"Effect of metformin on seizures in FeCl3 induced epileptic animal models","volume":"333","author":"Kumar","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0022","first-page":"49","article-title":"The effect of metformin treatment on endoplasmic reticulum (ER) stress induced by status epilepticus (SE) via the PERK-eIF2\u03b1-CHOP pathway","volume":"18","author":"Chen","year":"2018","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0023","doi-asserted-by":"crossref","first-page":"e03761","DOI":"10.1016\/j.heliyon.2020.e03761","article-title":"Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice","volume":"6","author":"Zeyghami","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0024","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10787-020-00782-8","article-title":"Metformin ameliorates the status epilepticus-induced hippocampal pathology through possible mtor modulation","volume":"29","author":"Bojja","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.seizure.2022.09.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100715","article-title":"The metformin in tuberous sclerosis (MiTS) study: a randomised double-blind placebo-controlled trial","volume":"32","author":"Amin","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.003_bib0026","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neulet.2011.03.071","article-title":"The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis","volume":"497","author":"Dudek","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.seizure.2022.09.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Pitk\u00e4nen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6","key":"10.1016\/j.seizure.2022.09.003_bib0028","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.seizure.2022.09.003_bib0029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neuroscience.2004.06.078","article-title":"Differential upregulation of extracellular matrix molecules associated with the appearance of granule cell dispersion and mossy fiber sprouting during epileptogenesis in a murine model of temporal lobe epilepsy","volume":"129","author":"Heck","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.seizure.2022.09.003_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2013.12.022","article-title":"Hippocampal granule cell pathology in epilepsy\u2014a possible structural basis for comorbidities of epilepsy?","volume":"38","author":"Hester","year":"2014","journal-title":"Epilepsy Behav."},{"issue":"21","key":"10.1016\/j.seizure.2022.09.003_bib0031","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.seizure.2022.09.003_bib0032","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-pharmtox-010814-124607","article-title":"Candidate drug targets for prevention or modification of epilepsy","volume":"55","author":"Varvel","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0033","doi-asserted-by":"crossref","unstructured":"McNamara J.O., Scharfman H.E. Temporal Lobe Epilepsy and the BDNF Receptor, TrkB. In: Noebels J.L., Avoli M., Rogawski M.A., et\u00a0al., editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK98186\/.","DOI":"10.1093\/med\/9780199746545.003.0039"},{"key":"10.1016\/j.seizure.2022.09.003_bib0034","series-title":"Issues in Clinical Epileptology: A View from the Bench","first-page":"133","article-title":"Is plasticity of GABAergic mechanisms relevant to epileptogenesis?","author":"Scharfman","year":"2014"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.003_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-014-0223-x","article-title":"mTOR inhibition in epilepsy: rationale and clinical perspectives","volume":"29","author":"Ostendorf","year":"2015","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.003_bib0036","doi-asserted-by":"crossref","first-page":"e64078","DOI":"10.1371\/journal.pone.0064078","article-title":"Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.seizure.2022.09.003_bib0037","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/hmg\/dds156","article-title":"The differential effects of prenatal and\/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex","volume":"21","author":"Way","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"10056","key":"10.1016\/j.seizure.2022.09.003_bib0038","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet North Am. Ed."},{"issue":"6","key":"10.1016\/j.seizure.2022.09.003_bib0039","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.seizure.2022.09.003_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci. (Colch)"},{"key":"10.1016\/j.seizure.2022.09.003_bib0041","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-gradechronic inflammation in polycystic ovary syndrome and the beneficialeffect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.seizure.2022.09.003_bib0042","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000221429.94591.72","article-title":"Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells","volume":"47","author":"Hattori","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.seizure.2022.09.003_bib0043","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK andpseudo-starvation","volume":"493","author":"O'Neill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.seizure.2022.09.003_bib0044","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41582-018-0057-0","article-title":"Lafora disease \u2013 from pathogenesis to treatment strategies","volume":"14","author":"Nitschke","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6234758","article-title":"The effect of metformin in experimentally induced animal models of epileptic seizure","volume":"2019","author":"Yimer","year":"2019","journal-title":"Behav. Neurol."},{"issue":"5","key":"10.1016\/j.seizure.2022.09.003_bib0047","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14737175.2018.1465410","article-title":"Oxidative stress in epilepsy","volume":"18","author":"Geronzi","year":"2018","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.seizure.2022.09.003_bib0048","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Armenta, M., Nava-Ru\u00edz, C., Ju\u00e1rez-Rebollar, D., Rodr\u00edguez-Mart\u00ednez, E., & G\u00f3mez, P. Y. (2014). Oxidative stress associated with neuronal apoptosis in experimental models of epilepsy. Oxid Med Cell Longev. 2014; 2014, 293689.","DOI":"10.1155\/2014\/293689"},{"key":"10.1016\/j.seizure.2022.09.003_bib0049","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2018.11.038","article-title":"Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy","volume":"146","author":"Ahmadian","year":"2019","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.003_bib0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2337\/diabetes.55.02.06.db05-1064","article-title":"Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase","volume":"55","author":"Davis","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.003_bib0051","article-title":"Neuroprotective effect of vitamin C against PTZ induced apoptotic neurodegeneration in adult rat brain","volume":"24","author":"Naseer","year":"2011","journal-title":"Pak J Pharm Sci"},{"issue":"10","key":"10.1016\/j.seizure.2022.09.003_bib0052","doi-asserted-by":"crossref","first-page":"e2441","DOI":"10.1038\/cddis.2016.334","article-title":"Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death. Dis."},{"issue":"10","key":"10.1016\/j.seizure.2022.09.003_bib0053","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/00207454.2018.1441149","article-title":"Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis","volume":"128","author":"Singh","year":"2018","journal-title":"Int. J. Neurosci."},{"issue":"18","key":"10.1016\/j.seizure.2022.09.003_bib0054","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","article-title":"Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy","volume":"38","author":"Rempe","year":"2018","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0055","first-page":"65","article-title":"LKB1 and AMP-activated protein kinase control of mTOR signalling and growth","volume":"196","author":"Shaw","year":"2009","journal-title":"Actaphysiologica"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.003_bib0056","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s12035-015-9091-8","article-title":"Pharmacological interventions to ameliorate neuropathological symptoms in a mouse model of Lafora disease","volume":"53","author":"Berthier","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0057","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","article-title":"mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis","volume":"107","author":"Citraro","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.seizure.2022.09.003_bib0058","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.seizure.2015.02.007","article-title":"Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy","volume":"27","author":"Rong","year":"2015","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.003_bib0059","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/CCLM.2011.077","article-title":"\u03b1-Synuclein in Parkinson disease and other neurodegenerative disorders","volume":"49","author":"Eller","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.seizure.2022.09.003_bib0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/01616412.2019.1576358","article-title":"Downregulated hippocampal expression of brain derived neurotrophic factor and tyrosine kinase B in a rat model of comorbid epilepsy and depression","volume":"41","author":"Liu","year":"2019","journal-title":"Neurol. Res."},{"issue":"10","key":"10.1016\/j.seizure.2022.09.003_bib0061","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/brain\/awy242","article-title":"Evidence for peri-ictal blood\u2013brain barrier dysfunction in patients with epilepsy","volume":"141","author":"R\u00fcber","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2022.09.003_bib0062","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/615829","article-title":"The blood-brain barrier and microvascular water exchange in Alzheimer's disease","volume":"2011","author":"Anderson","year":"2011","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0063","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/765923","article-title":"Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy","volume":"2011","author":"Tomkins","year":"2011","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.seizure.2022.09.003_bib0064","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/609202","article-title":"Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus","volume":"2011","author":"Serlin","year":"2011","journal-title":"Cardiovasc. Psychiatry Neurol."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-014-0177-4","article-title":"Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion","volume":"11","author":"Liu","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"9114","key":"10.1016\/j.seizure.2022.09.003_bib0066","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O'Callaghan","year":"1998","journal-title":"Lancet North Am. Ed."},{"issue":"3","key":"10.1016\/j.seizure.2022.09.003_bib0067","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13760-019-01090-x","article-title":"Impact of epilepsy duration, seizure control and EEG abnormalities on cognitive impairment in drug-resistant epilepsy patients","volume":"119","author":"Gavrilovic","year":"2019","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0068","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ncl.2015.08.008","article-title":"Treatment of cognitive deficits in epilepsy","volume":"34","author":"Leeman-Markowski","year":"2016","journal-title":"Neurol. Clin."},{"issue":"7","key":"10.1016\/j.seizure.2022.09.003_bib0069","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14737175.2019.1629289","article-title":"The overlap between epilepsy and Alzheimer's disease and the consequences for treatment","volume":"19","author":"Powell","year":"2019","journal-title":"Expert. Rev. Neurother."},{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2011.00251.x","article-title":"Seizures and epilepsy in Alzheimer's disease","volume":"18","author":"Friedman","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.seizure.2022.09.003_bib0071","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yebeh.2012.11.040","article-title":"Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms","volume":"26","author":"Chin","year":"2013","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.seizure.2022.09.003_bib0072","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1570159X11666131120223201","article-title":"Metformin eased cognitive impairment induced by chronic L-methionine administration: potential role of oxidative stress","volume":"12","author":"Alzoubi","year":"2014","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0073","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12031-007-9002-1","article-title":"Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons","volume":"34","author":"El-Mir","year":"2008","journal-title":"J. Mol. Neurosci."},{"issue":"11-12","key":"10.1016\/j.seizure.2022.09.003_bib0074","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lfs.2012.08.017","article-title":"Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats","volume":"91","author":"Pintana","year":"2012","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.seizure.2022.09.003_bib0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/bies.200900003","article-title":"Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy","volume":"31","author":"Poels","year":"2009","journal-title":"Bioessays"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0076","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2016.05.148","article-title":"Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury","volume":"477","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.seizure.2022.09.003_bib0077","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2012.03.016","article-title":"Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.003_bib0078","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pharep.2019.04.015","article-title":"The protective effect of metformin in scopolamine-induced learning and memory impairment in rats","volume":"71","author":"Aksoz","year":"2019","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.seizure.2022.09.003_bib0079","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.seizure.2022.09.003_bib0080","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3233\/JAD-181240","article-title":"Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer's disease","volume":"68","author":"Farr","year":"2019","journal-title":"J. Alzheimers Dis."}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:04:22Z","timestamp":1761012262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":80,"alternative-id":["S1059131122001960"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.09.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}